Cargando…

PW01-002 – Colchicine resistant FMF in Turkish children

Detalles Bibliográficos
Autores principales:	Eroglu, FK Kara, Bilginer, Y, Ozaltin, F, Topaloglu, R, Ozen, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952573/ http://dx.doi.org/10.1186/1546-0096-11-S1-A55

Ejemplares similares

PW01-005 – Effects of placebo and colchicine on FMF patients
por: Özaltın, F, et al.
Publicado: (2013)

PW01-025 – Definition of colchicine resistance in FMF
por: Demirkaya, E, et al.
Publicado: (2013)

PW01-015 – Canakinumab in adults with colchicin resistant FMF
por: Gül, A, et al.
Publicado: (2013)

PW03-001 - PFAPA syndrome in Turkish children
por: Batu, ED, et al.
Publicado: (2013)

PW01-006 – The effect of colchicine on physical growth in FMF
por: Cakar, N, et al.
Publicado: (2013)

PW01-007 – Colchicine brand switching in FMF patients
por: Jagger, J, et al.
Publicado: (2013)

PReS-FINAL-2218: Treatment of colchicines resistant FMF: experience of a pediatric center in Turkey
por: Kara Eroglu, F, et al.
Publicado: (2013)

P02-020 - CAPS in Turkish children: treatment with ANTI IL1
por: Eroglu, FK Kara, et al.
Publicado: (2013)

PW01-012 – Canakinumab in patients with FMF
por: Ugurlu, S, et al.
Publicado: (2013)

PW01-030 – Pulmonary manifestations of FMF
por: Sargsyan, AV, et al.
Publicado: (2013)

PW01-033 – Phenotype – genotype in Armenian children with FMF
por: Amaryan, G, et al.
Publicado: (2013)

PW01-026 – Validation of pediatric diagnostic criteria in FMF
por: Demirkaya, E, et al.
Publicado: (2013)

PW01-028 – Developing a new severity score for FMF
por: Demirkaya, E, et al.
Publicado: (2013)

PW01-018 – Circulating endothelial biomarkers in FMF
por: Sari, I, et al.
Publicado: (2013)

PW01-008 – The inflammasome and secretory pathways in FMF
por: Orak, B, et al.
Publicado: (2013)

P01-031 – Anakinra for colchicine resistant FMF
por: Ben-Zvi, I, et al.
Publicado: (2013)

PW01-036 – Renal replacement therapy in patients with FMF
por: Papazyan, M, et al.
Publicado: (2013)

PW01-011 – Exertional leg pain and spondyloarthropathy on FMF
por: Rosman, Y, et al.
Publicado: (2013)

PW01-016 – Are different disease subtypes present in FMF
por: Akar, S, et al.
Publicado: (2013)

PW01-009 – Markers of inflammation in adult FMF patients
por: Giese, A, et al.
Publicado: (2013)

PW01-010 – The effect of pregnancy on disease course in FMF
por: Eviatar, T, et al.
Publicado: (2013)

PW01-034 – Clinical-genetic investigation of FMF in Armenia
por: Hayrapetyan, H, et al.
Publicado: (2013)

PW01-031 – Treatment of FMF in middle and old age
por: Ayvazyan, A
Publicado: (2013)

PW01-027 – Predictors and survival of FMF related amyloidosis
por: Demirkaya, E, et al.
Publicado: (2013)

PW01-022 – Dissociation between CRP and SAA in FMF
por: Stojanovic, K Stankovic, et al.
Publicado: (2013)

PW01-004 – The sequence analysis in E148Q homozygous patients
por: Topaloglu, R, et al.
Publicado: (2013)

PW01-021 – The phenotype of FMF due to deletion M694
por: Lachmann, HJ, et al.
Publicado: (2013)

PW01-014 – MEFV methylation analysis in FMF and JRA diseases
por: Turanli, E Tahir, et al.
Publicado: (2013)

P01-027 – Normal HRV in colchicine-resistant FMF patients
por: Nussinovitch, U, et al.
Publicado: (2013)

PW01-023 – Ex vivo PBMC cytokine profile in FMF patients
por: Ibrahim, JN, et al.
Publicado: (2013)

PW01-024 – Phenotypic analysis of a MEFV negative FMF cohort
por: Soriano, A, et al.
Publicado: (2013)

PW01-032 – FMF-like state: genetic factors unrelated to MEFV
por: Babikyan, D, et al.
Publicado: (2013)

PW01-017 – Urine MMP-3 level as a biomarker for in FMF attack
por: Sozeri, B, et al.
Publicado: (2013)

P01-009 – 2 years of colchicine IV in intractable FMF
por: Kaly, L, et al.
Publicado: (2013)

P01-002 – Comparison between different colchicines responders
por: Özçakar, ZB, et al.
Publicado: (2013)

P01-039 – Autonomic functions in children with FMF
por: Fidanci, K, et al.
Publicado: (2013)

PW01-003 – Frequency of MEFV mutations in Turkish population
por: Yalcinkaya, F, et al.
Publicado: (2013)

OR2-002 – The risk of FMF in MEFV heterozygotes
por: Jéru, I, et al.
Publicado: (2013)

OR7-005 – Canakinumab in childhood colchicine resistant FMF
por: Hashkes, PJ, et al.
Publicado: (2013)

P01-013 – Cochlear involvement in FMF
por: Ayaz, N Aktay, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_p59c8v1j59clb8dd8u9srv3s15